Cytarabine 20 mg/ml Solution for Injection/Infusion Irlanda - inglese - HPRA (Health Products Regulatory Authority)

cytarabine 20 mg/ml solution for injection/infusion

accord healthcare limited - cytarabine - solution for injection/infusion - 20 milligram(s)/millilitre - pyrimidine analogues; cytarabine

Cytarabine 20 mg/ml Solution for Injection/Infusion Irlanda - inglese - HPRA (Health Products Regulatory Authority)

cytarabine 20 mg/ml solution for injection/infusion

accord healthcare ireland ltd. - cytarabine - solution for injection/infusion - 20 milligram(s)/millilitre - pyrimidine analogues; cytarabine

Cytarabine 100 mg/ml Solution for Injection or Infusion Irlanda - inglese - HPRA (Health Products Regulatory Authority)

cytarabine 100 mg/ml solution for injection or infusion

fresenius kabi deutschland gmbh - cytarabine - solution for injection/infusion - 100 milligram(s)/millilitre - pyrimidine analogues; cytarabine

Cytarabine 100 mg/ml solution for injection or infusion Irlanda - inglese - HPRA (Health Products Regulatory Authority)

cytarabine 100 mg/ml solution for injection or infusion

accord healthcare ireland ltd. - cytarabine - solution for injection/infusion - 100 milligram(s)/millilitre - pyrimidine analogues; cytarabine

Cytarabine 100mg/ml injection Solution for Injection 100mg/ml (5mL) Malta - inglese - Medicines Authority

cytarabine 100mg/ml injection solution for injection 100mg/ml (5ml)

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - cytarabine - solution for injection - cytarabine 100 mg/ml - antineoplastic agents

Cytarabine 100mg/ml injection Solution for Injection 100mg/ml (20mL) Malta - inglese - Medicines Authority

cytarabine 100mg/ml injection solution for injection 100mg/ml (20ml)

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - cytarabine - solution for injection - cytarabine 100 mg/ml - antineoplastic agents

CYTARABINE injection, solution Stati Uniti - inglese - NLM (National Library of Medicine)

cytarabine injection, solution

gland pharma limited - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia. cytarabine injection is contraindicated in those patients who are hypersensitive to the drug.